BTG INTERNATIONAL LIMITED et al v. AMERIGEN PHARMACEUTICALS, INC. et al
| BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH, INC., JANSSEN ONCOLOGY, INC. and JANSSEN RESEARCH & DEVELOPMENT, LLC. |
| AMERIGEN PHARMACEUTICALS, INC. and AMERIGEN PHARMACEUTICALS LTD. |
| AMERIGEN PHARMACEUTICALS, INC. and AMERIGEN PHARMACEUTICALS LTD. |
| BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH, INC., JANSSEN ONCOLOGY, INC. and JANSSEN RESEARCH & DEVELOPMENT, LLC. |
| 2:2016cv02449 |
| May 2, 2016 |
| US District Court for the District of New Jersey |
| Newark Office |
| Bergen |
| James B. Clark |
| Kevin McNulty |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
43
CONSOLIDATED OPINION (Amended). Filed herewith is an amended version of the Court's 38 Opinion of October 26, 2018. Footnote 13 is revised and extended to summarize the court's reasoning on the record as to finality and section 315(e) estoppel. Signed by Judge Kevin McNulty on 10/31/18. (nic, )
|
|
Filing
38
OPINION. Signed by Judge Kevin McNulty on 10/26/2018. (dam, )
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
